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Abstract
The encapsulation and delivery of short interfering RNA (siRNA) has been realized using lipid
nanoparticles1,2, cationic complexes3,4, inorganic nanoparticles5–8, RNA nanoparticles9,10 and
dendrimers11. Still, the instability of RNA and the relatively ineffectual encapsulation process of
siRNA remain critical issues towards the clinical translation of RNA as a therapeutic1,12,13. Here
we report the synthesis of a delivery vehicle that combines carrier and cargo: RNA interference
(RNAi) polymers that self-assemble into nanoscale pleated sheets of hairpin RNA, which in turn
form sponge-like microspheres. The RNAi-microsponges consist entirely of cleavable RNA
strands, and are processed by the cell’s RNA machinery to convert the stable hairpin RNA to
siRNA only after cellular uptake, thus inherently providing protection for siRNA during delivery
and transport to the cytoplasm. More than half a million copies of siRNA can be delivered to a cell
with the uptake of a single RNAi-microsponge. The approach could lead to novel therapeutic
routes for siRNA delivery.
RNA interference (RNAi) is a powerful tool for suppressing gene expression, and much
research has been directed at efforts to develop an efficient delivery method for short
interfering RNA (siRNA; refs 1,2). Conventional complexation or encapsulation of siRNA
with polymers or lipids can often require multi-step synthesis of carriers5,13,14 or relatively
ineffectual encapsulation processes; furthermore, such approaches often involve introducing
a significant amount of an additional component, which can lead to greater potential for
immunogenic response or toxicity. Furthermore, the amount of siRNA per carrier is limited
owing to the rigidity of double-stranded siRNA, low surface charge of individual siRNA,
and low loading efficiency5,9, making RNAi encapsulation particularly challenging.
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Furthermore, RNAi requires specialized synthesis and is often available only in small
quantities at high cost, making it a very costly cargo that is delivered with fairly low
efficiency carriers. A different and potentially valuable approach would be to use the DNA/
RNA machinery15–18 provided by nature to generate RNAi in polymeric form, and in a
manner that actually assembles into its own compact delivery cargo system. In this way, the
RNAi is generated in a stable form with multiple copy numbers at low cost, and distributed
in a form that can readily be adapted for systemic or targeted delivery.
By taking advantage of new RNA synthetic methods16–19 for the generation of
nanostructures via rational design20–24, we use an enzymatic RNA polymerization to form
condensed RNA structures that contain predetermined sequences for RNAi by rolling circle
transcription25 (RCT). Seyhan et al. has previously used the RCT route for generating
multimeric transcripts26; however, the resulting RNA does not self-assemble into
nanostructures, but forms solubilized lower molecular weight strands. By rational design, we
use RNA polymerase to generate elongated pure RNA strands as polymers that can self-
assemble into organized nano- to microstructures, which is key for efficient delivery and
high cargo capacity, offering the combined benefit of low off-target effects and low
toxicity4. Using a new approach, we use the T7 promoter as a primer so that extremely high
molecular weight RNA strands can be produced. As shown in Fig. 1, long linear single-
stranded DNA encoding complementary sequences of the antisense and sense sequences of
anti-luciferase siRNA are first prepared. Because both ends of the linear DNA are also
partially complementary to the T7 promoter sequence, the long strand is hybridized with a
short DNA strand containing the T7 promoter sequence to form circular DNA [1] (see
Supplementary Table S1). The nick in the circular DNA is chemically closed with a T4
DNA ligase [2]. The closed circular DNA is then used to produce RNA transcripts via RCT,
encoding both antisense and sense sequences of anti-luciferase siRNA, yielding hairpin
RNA structures [3] (see Supplementary Fig. S1). The hairpin RNA structures can actively
silence genes when converted to siRNA by Dicer. From in vitro RCT of the circular DNA,
we can obtain multiple tandem copies of the sequence in coils of single-stranded and
double-stranded RNA transcripts. Although the products might be compared to DNA
toroidal condensates27,28, in this case, there is no charged condensing element that assists in
the formation of the structure.
The RNA transcripts form porous sponge-like superstructures with a nanoscopic structure
readily visible in the scanning electron microscope (SEM) image (Fig. 2a). Because of the
structural similarity, we refer to the resulting RNA product as an RNAi-microsponge.
Unlike conventional nucleic acid systems29, our RNAi-microsponge exhibits a densely
packed molecular scale structure without the use of an additional agent. We confirmed that
the RNAi-microsponges are composed of RNA by staining with SYBR II and labelling with
Cyanine 5-dUTP, and observing the resulting bright green and red fluorescence, respectively
(Fig. 2b and Supplementary Fig. S2). Also, we provide further evidence with an RNase
digestion experiment at various concentrations of RNase. The results clearly show the rate-
dependent degradation of the RNA-microsponge at high concentrations of RNase
(Supplementary Fig. S3). Monodisperse RNA-microsponges were prepared with short
sonication (Fig. 2c and Supplementary Information). The particles exhibit a uniform size of
2 μm, and consistent nanoscale pleated or fan-like spherical morphology. On the basis of the
molecular weight and concentration, each RNAi-microsponge contains approximately a half
million tandem copies of RNA strands that are cleavable with Dicer (see Supplementary
Information). A higher magnification SEM image of the RNA particles reveals that the
sponge-like structure is constructed from RNA sheets which are approximately 12 ± 4 nm
thick (Fig. 2d).
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To examine the formation of the sponge-like spherical structures from their RNA strand
building blocks, time-dependent experiments were performed during the RCT
polymerization. The morphologies of the RNA superstructures were revealed by SEM after
1 h, 4 h, 8 h, 12 h, 16 h and 20 h RCT reaction time. As shown in Fig. 3a, the RCT products
first form a fibre-like structure in the early stages of the polymerization. After further
reaction time, a sheet-like structure is formed (Fig. 3b). At the 8 h time-point, the sheet-like
structure became thicker and began to exhibit a densely packed internal structure (Fig. 3c).
Wrinkled and semi-spherical structures begin to appear on the sheet structures in the 12 h
reaction sample (Fig. 3d and Supplementary Fig. S4). After 16 h, the morphology of the
RNA polymer product transforms into interconnected globular superstructures in which the
sheets are re-organized into a complex buckled and folded internal structure (Fig. 3e). These
spherical structures start to separate into individual particles, and after 20 h, the final
spherical sponge-like structures were observed (Figs 3f and 2a). Based on the SEM images
from time-dependent experiments, a schematic cartoon of the process of formation of the
sponge-like superstructure is suggested in Fig. 3g. The final structure is reminiscent of the
lamellar spherulite structures that are formed by highly crystalline polymers when nucleated
in the bulk state or solution30. In the case of traditional synthetic polymers such as
polyethylene or polyethylene oxide, the thickness of the lamellar sheets corresponds to the
dimensions of chain-folded polymer molecules. It is possible that as the RNA polymer is
continuously generated during the RCT reaction, and reaches very high molecular weight at
high localized concentrations, a similar ordering and assembly process occurs here31. Thus
far, such a self-assembled crystalline superstructure has not been observed for RNA
polymers. The crystalline structure of RNAi-microsponges was confirmed by polarizing
optical microscopy (POM); under crossed polarizers, birefringence of the individual
particles is observed (Fig. 3h). In comparison to the SEM image (inset of Fig. 2c), it seems
that the RNA sheet has a crystal-like ordered structure (inset of Fig. 3h). X-ray diffraction
further confirmed the crystalline structure of the RNAi-microsponge (Fig. 3i). The crystallite
thickness is estimated to be ~7.4 nm, as determined from the Scherrer equation
(Supplementary Table S2 and Supplementary Information). This finding is consistent with
the thickness from SEM images, although the resolution of SEM is not as sensitive at the
nanoscale. Furthermore, transmission electron microscope (TEM) images (Fig. 3j and
Supplementary Fig. S5) showing densely assembled RNA sheet structures in the RNAi-
microsponge support the proposed structure, as shown in schematic in Fig. 3j. Similar to
liquid crystal phases from duplex DNA (ref. 32), the high molecular weight of RNA
polymers with periodic RNA duplexes leads to the formation of crystal-like ordered
structures. The melting experiment using POM with a heating stage shows that the RNAi-
microsponge is pretty stable up to 150 °C, which is much higher than the melting
temperature of any double helix DNA or RNA molecules, suggesting that the formation of
the RNAi-microsponge is dominantly based on the ordered crystalline structure of RNA
polymers (Supplementary Fig. S6). The assembly of the RNA polymer was also observed
when polymerized at different concentrations of the rolling circle DNA polymerizing or
initiating units (Supplementary Fig. S7). At lower concentrations, individual branched
dendritic polycrystals were formed in solution, but they did not assemble into microparticles
until a critical concentration of DNA was achieved. The concentration dependence, the
appearance of more traditional crystalline structures at low concentration, as well as the
observed crystallite thickness of 7.4 nm for the sponge layer structures, which corresponds
to the length of the rigid 21 base pair (bp) RNA repeat sequence, were all consistent with
phenomena observed for the formation of spherulitic superstructures of chain-folded
lamellar sheets30.
The RNAi-microsponges have a highly localized concentration of RNA strands, as they
essentially consist of near 100% potential RNAi. For this reason, these systems should be an
effective means to deliver and generate siRNA through intracellular processing mechanisms.
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The RNA structures were designed to be cleaved by the enzyme Dicer by cutting double-
stranded RNA into approximately 21 nucleotide RNA duplexes in the cytoplasm33, where it
can be converted to siRNA by the RNA-induced silencing complex (RISC) for gene
silencing (Fig. 4a). To confirm Dicer cleavage of RNAi-microsponges, they were incubated
with recombinant Dicer and the products were analysed by gel electrophoresis (Fig. 4b). In
the presence of recombinant Dicer, RNAi-microsponges yielded 21-bp products (Fig. 4b,
left), whereas there are no RNA strands as small as the 21-bp siRNA without Dicer
treatment (lane 2 of Fig. 4b, right). Owing to the amount of cleavable RNA strands and the
size of the RNAi-microsponge, recombinant Dicer required at least a 36 h reaction time to
generate the maximum amount of siRNA (lanes 3–8 of Fig. 4b, right). 9.5% (w/w) of RNAi-
microsponges were converted to siRNA, indicating that 21% of the cleavable double-
stranded RNA was actually diced to siRNA (Supplementary Table S3 and Supplementary
Information). Dicer also produced the two or three repeat RNA units (Fig. 4b). With these
results, we estimate that each individual RNAi-microsponges can yield ~102,000 siRNA
copies (see Supplementary Information).
To enhance the cellular uptake of the RNA particle, the synthetic polycation,
polyethylenimine (PEI) was used to condense the RNAi-microsponge and generate a net
positively charged outer layer34. Owing to the high negative charge density of the RNAi-
microsponge, cationic PEI was readily adsorbed onto the particles by electrostatic
interaction. The change of particle surface charge (zeta potential) from −20 mV (RNAi-
microsponge) to +38 mV (RNAi-microsponge/PEI) indicates the successful assembly of
RNAi-microsponges with PEI (Fig. 4c). The size of the particles decreased significantly to
200 nm from the original average size of approximately 2 μm (Fig. 4c). The shrinking was
also confirmed by SEM, showing approximately 200 nm monodisperse particles (Fig. 4d
and Supplementary Fig. S8). It is worth noting that a single PEI-layered RNAi-microsponge
still contains the same number of cleavable RNA strands, thus yielding an extremely high
siRNA density. To the best of our knowledge, this represents the highest number of siRNA
molecular copies encapsulated in a nanoparticle; typically the loading of siRNA can be
challenging for standard polymeric carriers.
To confirm the cellular transfection of the RNA particles, red fluorescence labelled RNAi-
microsponge/PEI was incubated with T22 cells. RNAi-microsponge/PEI particles exhibited
significant cellular uptake by the cancer cell line, compared with the uncondensed RNAi-
microsponges (Fig. 5a). Because the RNAi-microsponge was designed to generate siRNA
for silencing of firefly luciferase expression, the drug efficacy was determined by measuring
the fluorescence intensity of cell lysate after transfection (Fig. 5b and Supplementary Fig.
S9). As expected, naked siRNA did not show any significant gene silencing up to 100 nM
siRNA, whereas RNAi-microsponges showed slightly reduced gene expression at 980.0 fM.
PEI-layered RNAi-microsponges efficiently inhibited the firefly luciferase expression down
to 42.4% at a concentration of 980 fM. The RNAi-MS/PEI delivery system shows better
silencing efficiency than siRNA/PEI. The level of gene knockdown was also evaluated with
in vivo optical images of firefly luciferase expression in tumours after intratumoral injection
of RNAi-microsponge/PEI (Fig. 5c and Supplementary Fig. S10). As can be seen in Fig. 5c,
after four days the level of firefly luciferase expression in the tumour was significantly
reduced for the PEI-layered RNAi-microsponges; however, there is no significant decrease
in firefly luciferase expression with a control RNA-microsponge/PEI that does not knock
down luciferase (Supplementary Fig. S11). Note that extremely low numbers (2.1 fmol) of
RNAi-microsponge/PEI particles were used to achieve significant gene silencing efficiency
—roughly three orders of magnitude less carrier was required to achieve the same degree of
gene silencing as a conventional particle-based vehicle6. Compared with other strategies,
siRNA delivery using our RNAi-microsponges provides synergistic effects for loading
efficiency, drug efficacy, and low cytotoxicity (Fig. 5b, c and Supplementary Fig. S12).
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We demonstrated a new class of siRNA carrier, the RNAi-microsponge, which introduces a
new self-assembled structure that provides a route for the effective delivery of siRNA. The
RNAi-microsponge presents a means of rapidly generating large amounts of siRNA in a
form that assembles directly into a drug carrier that can be used for direct transfection
simply by coating with a positively charged polyion. Given the high cost of therapeutic
siRNA and the need for high levels of efficiency, this approach could lead to much more
directly accessible routes to therapies involving siRNA. The siRNA, which is highly prone
to degradation during delivery, is protected within the microsponge in the crystalline form of
polymeric RNAi. We can significantly reduce the difficulties of achieving high loading
efficiency for siRNA using this approach. The microsponges are able to deliver the same
transfection efficiency with a three orders of magnitude lower concentration of siRNA
particles than typical commercially available nanoparticle-based delivery8. Furthermore, the
ease of modification of the RNA polymer composition enables the introduction of multiple
RNA species for combination therapies. The RNAi-microsponge presents a novel materials
system in general owing to its unique morphology and nanoscale structure within the
polymer particle, and provides a promising self-assembling material that spontaneously
generates a dense siRNA carrier for broad clinical applications of RNAi delivery using the
intrinsic biology of the cell.
Methods
In vitro RCT by T7 RNA polymerase to create RNA-microsponges
Ligased circular DNA templates (0.3 μM) were incubated with T7 RNA polymerase (5 units
μl−1) at 37 °C for 20 h in the reaction buffer (8 mM Tris-HCl, 0.4 mM spermidine, 1.2 mM
MgCl2, and 2 mM dithiothreitol) including 2 mM ribonucleotide tri-phosphate in the final
concentration. To fluorescently label the RNA particle, Cyanine 5-dUTP (0.5 mM) was
added. The resultant solution was pipetted several times and then sonicated for 5 min to
break any possible connection of the particles. The solution was centrifuged at 6,000 r.p.m.
for 6 min to remove the supernatant. Then, RNase-free water was added to wash the
particles. The solution was sonicated again for 1 min, then centrifuged. This washing step
was repeated three more times to remove the reagents of RCT. Measurement of the RNA-
microsponge concentration was conducted by measuring fluorescence using Quant-iT RNA
BR assay kits (Invitrogen). 10 μl of RNA-microsponge solution or standard solution was
incubated with 190 μl of working solution for 10 min at room temperature. The fluorescence
was measured at 630/660 nm using a Fluorolog-3 spectrofluorometer (Horiba Jobin Yvon).
Treatment of RNAi-microsponges with recombinant Dicer
RNAi-microsponges were digested with from 1 unit to 1.5 unit recombinant Dicer
(Genlantis, San Diego, CA) in 12 μl of reaction solution (1 mM adenosine tri-phosphate, 5
mM MgCl2, 40% (v/v) Dicer reaction buffer). The samples treated for different reaction
time from 12 h to 48 h were collected and were then inhibited by adding Dicer stop solution
(Genlantis, San Diego, California).
Degradation experiments of RNAi-microsponges
RNA-microsponges were incubated for 24 h in 10% of serum at 37 °C. Degradation
experiments with various concentrations of RNase were also performed for 24 h at 37 °C
(NEB, Ipswich, Massachusetts).
Characterization of RNAi-microsponges
JEOL JSM-6060 and JSM-6070 scanning electron microscopes were used to obtain high-
resolution digital images of the RNA-microsponges. The sample was coated with Au/Pd. A
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JEOL 2000FX transmission electron microscope was used to obtain the internal structure of
the RNA particle. A Zeiss AxioSkop 2 MAT fluorescent microscope was used to image
green fluorescently stained RNA-microsponges by SYBR II. To characterize the crystalline
structure of RNA-microsponges, laboratory X-ray powder diffraction (XRD) patterns were
recorded using a PANalytical X’Pert Pro diffractometer, fitted with a solid-state X’Celerator
detector. The diffractometer uses Cu Kα radiation (λ(Kα1) = 1.5406 Å, λ(Kα2) = 1.5433 Å,
weighted average λ = 1.5418 Å) and operates in a Bragg geometry. The data were collected
from 5° to 40° at a scan rate of 0.1° min−1.
Assembly of the PEI layer on RNAi-microsponges
For assembly of the outer layer, RNA-microsponges were mixed with PEI solution, used at a
final concentration of up to 5.0 mg ml−1. Free PEI was easily removed by centrifugation at
13,700 r.p.m. for 30 min. This step was repeated two more times. The PEI-layered RNA
particles were resuspended in PBS solution (pH 7.4) or MilliQ water.
In vitro siRNA knockdown experiments
T22 cells were maintained in growth media comprised of Minimum Essential Media-Alpha
Modification (MEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin–
streptomycin. Three days before knockdown experiments, cells were seeded in 6-well plates
at 30,000 cells per well. Two days before transfection, each well was co-transfected with 3.5
g each of pRL-CMV and gWiz-Luc using Fugene-HD according to the manufacturers
instructions. One day before transfection, cells were trypsinized and re-seeded in 96-well
plates at an initial seeding density of 2,000 cells per well. Cells were allowed to attach and
proliferate for 24 h. All knockdown experiments were performed in triplicate. 50 μl of
fluorescently labelled RNAi-MS and RNAi-MS/PEI were added to 250 μl phenol-free Opti-
MEM at the final concentration of up to 21.2 fM. Lipofectamine/siRNA complexes were
formed at a 4:1 ratio (v/w). The growth media were removed and Opti-MEM was added to
cells, followed by RNAi-microsponges or complexes in PBS, for a total volume of 150 μl
per well, with no less than 100 μl Opti-MEM per well. Cells were incubated with siRNA
constructs for 4 h, after which the media were removed and replaced with 10% serum-
containing growth medium. A luciferase assay was performed using the Dual-Glo
Luciferase Assay Kit (Promega, Madison, Wisconsin) and measured on a Perkin Elmer Plate
1420 Multilabel Counter plate reader. Green flourescent protein expression was measured
after quenching the luciferase signal with the Stop-and-Glo reagent from Promega.
In vivo siRNA knockdown experiments
T22-Luc is a genetically defined mouse ovarian cancer cell line (p53−/−, Akt, myc) that
stably expresses luciferase after infection with pMSCV-puro-firefly luciferase viral
supernatant and selecting the cells in a medium containing 2.0 μg ml−1 of puromycin for one
week. T22-Luc tumours were induced on both hind flanks of female nude mice (five weeks
old) with a single injection of 2–5 million cells in 0.1 ml media. After the tumours grew to
~100 mm (ref. 3) in volume, intratumoral injections of RNAi-microsponges were given in
volumes of 50 μl. To determine the degree of luciferase knockdown, D-Luciferin (Xenogen)
was given intraveneously (tail vein injection, 25 mg kg−1) and bioluminescence images were
collected on a Xenogen IVIS Spectrum Imaging System (Xenogen, Alameda, California) 10
min after injection. Living Image software Version 3.0 (Xenogen) was used to acquire and
quantitate the bioluminescence imaging data sets.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Schematic showing the process of rolling circle transcription (RCT) for the self-
assembled RNAi-microsponge
To perform RCT (ref. 35), circular DNA needs to be synthesized first (see Supplementary
Information). Linear single-stranded DNA that includes antisense and sense sequences of
anti-luciferase siRNA is hybridized with an equal molar amount of short DNA strands
containing the T7 promoter sequence. The nick in the circular DNA was chemically closed
by T4 DNA ligase. By RCT of the closed circular DNA, multiple tandem repeats of hairpin
RNA structures from both antisense and sense sequences are generated to be able to form
spherical sponge-like structures.
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Figure 2. Characterization of the RNAi-microsponge
a, SEM image of RNAi-microsponges. b, Fluorescence microscope image of RNAi-
microsponges after staining with SYBR II, an RNA-specific dye. c, d, SEM images of
RNAi-microsponges after sonication. Low-magnification image of an RNAi-microsponges
(c). High-magnification image of an RNAi-microsponge (d).
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Figure 3. Formation of sponge-like spherical structures purely with RNA strands
a–e, SEM images of RNA products of time-dependent RCT at 37 °C for 1 h (a), 4 h (b), 8 h
(c), 12 h (d) and 16 h (e). Inset: scale bar, 500 nm. f, Image of mature RNAi-microsponges
after 20 h RCT. g, Schematic of the formation of RNAi-microsponges. The spherical
sponge-like structure is formed through a series of preliminary structures. A tandem copy of
RNA strands from the RCT reaction are entangled and twisted into a fibre-like structure 1.
As the RNA strands grow, they begin to organize into lamellar sheets that gradually become
thicker 2; as the internal structure of the sheets begins to get very dense, some of the RNA
sheets begin to grow in the z direction, possibly owing to the limited packing area for the
RNA polymer as it is produced by the reaction. This process could generate a wrinkled
semi-spherical structure on the sheet 3. Finally, the entire structure begins to pinch off to
form individual particles consisting of gathered RNA sheets 4. h, Polarized optical
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microscopy of RNAi-microsponges. i, X-ray diffraction pattern of RNAi-microsponges. j,
TEM images of RNAi-microsponges and schematic representation of the proposed crystal-
like ordered structure of an RNA sheet in the microsponge. Inset: scale bar, 500 nm.
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Figure 4. Generating siRNA from RNAi-microsponges by the RNAi pathway, and condensing
RNAi-microsponges for transfection
a, Schematic of the generation of siRNA from RNAi-microsponges by Dicer in the RNAi
pathway. b, Gel-electrophoresis result after Dicer reaction. On the left, lanes 1 and 2
indicate double-stranded RNA ladder and RNAi-microsponges (MS) after treatment with
Dicer (1 unit) for 36 h, respectively. On the right, lanes 1 and 2 indicate double-stranded
RNA ladder and RNAi-microsponges without Dicer treatment. Lanes 3–8 correspond to 12
h, 24 h, 36 h and 48 h reaction with 1 unit of Dicer, and 36 h reaction with 1.25 and 1.5 units
of Dicer, respectively. Increasing the amount of Dicer did not help to generate more siRNA
(lane 7 and 8 of b). The amount of generated siRNA from RNAi-microsponges was
quantified relative to double-stranded RNA standards. 21% of the cleavable double-stranded
RNA was actually diced to siRNA because Dicer also produced the two or three repeat RNA
units. The results suggest the possibility that in a more close-packed self-assembled
structure, some portion of the RNA is not as readily accessed by Dicer. c, Particle size and
zeta potential before and after condensing RNAi-microsponges with PEI. d, SEM image of
further condensed RNAi-microsponges with PEI. The size of the RNAi-microsponges was
significantly reduced by linear PEI because the RNAi-microsponges with high charge
density would be more readily complexed with oppositely charged polycations. The porous
structure of the RNAi-microsponges disappeared following condensation.
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Figure 5. Transfection and gene silencing effect
a, Intracellular uptake of red fluorescent dye-labelled RNAi-microsponges without PEI (top)
and RNAi-microsponge/PEI (bottom). To confirm the cellular transfection of RNA particles,
both types of particles, labelled for red fluorescence, were incubated with T22 cells.
Fluorescence labelled RNAi-microsponges without a PEI outer layer showed relatively less
cellular uptake by the cancer cell line (T22 cells) suggesting that the larger size and strong
net negative surface charge of RNAi-microsponges probably prevents cellular
internalization. Inset: scale bar, 5 μm. b, Suppression of luciferase expression by siRNA,
Lipofectamine complexed with siRNA (siRNA/Lipo), siRNA complex with PEI (siRNA/
PEI), RNAi-microsponge (RNAi-MS), and RNAi-microsponge condensed by PEI (RNAi-
MS/PEI). The same amount of siRNA is theoretically produced from RNAi-microsponges at
the concentration in parentheses. c, In vivo knockdown of firefly luciferase by RNAi-MS/
PEI. Optical images of tumours after intratumoral injection of RNAi-MS/PEI into the left
tumour of a mouse and PEI solution only as a control into the right tumour of the same
mouse.
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